Publication of the 2024 Interim Financial
Publication of the 2024 Interim Financial Report Paris, France (July 26, 2024 – 6:30 pm) – The Board of Directors ...
Read morePublication of the 2024 Interim Financial Report Paris, France (July 26, 2024 – 6:30 pm) – The Board of Directors ...
Read moreRobotic HIFU therapy continues to maintain an excellent safety profile, confirming positive safety data from prior ...
Read more- Independent committee confirms FALCON study is powered for potential success with both alternative endpoints passing futility- -Committee confirms strong ...
Read more– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had ...
Read moreRobust reduction in anti-VEGF injection treatment burden through Week 24 achieved in 30 patients at planned Phase 3 dose (3E10 ...
Read moreMr. Mack is the Company’s Current CFO Khalid Islam, PhD, Founder and Chairman of the Board, to serve as Executive ...
Read more100% of evaluable participants at Month 6 achieved target absolute neutrophil count (ANC) increase with once-daily, oral mavorixafor +/- stable-dose ...
Read more24-week landmark safety and clinical activity data for 45 patients enrolled in the Population Extension cohort expected to be presented ...
Read more– Observed 67% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial complete remission (CR)/marrow complete ...
Read moreClinically meaningful improvements in ppFEV1 at 12 months observed in 2 of 3 participants with mild to moderate baseline lung ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.